The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat
- 1 August 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 153 (1) , 33-44
- https://doi.org/10.1016/0014-2999(88)90585-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primatesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluidLife Sciences, 1986
- Dopamine Metabolites in Rat Cisternal Cerebrospinal Fluid: Major Contribution from Extrastriatal Dopamine NeuronesJournal of Neurochemistry, 1986
- Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Conjugates of Dopamine and Serotonin in Ventriculocisternal Perfusates of the CatJournal of Neurochemistry, 1984
- Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrainActa Physiologica Scandinavica, 1982
- 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptorsLife Sciences, 1981
- DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHYJournal of Neurochemistry, 1978
- Regulation of noradrenaline release by presynaptic receptor systemsPublished by Springer Nature ,1977
- On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric methodLife Sciences, 1963